ReviewFrontiers in pharmacology2026
Amphetamine-type stimulants in young adults with ADHD: effects on sleep, circadian rhythms, and neuropsychiatric outcomes.
Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Amphetamine-type stimulants are widely prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD) and are commonly used by college-aged individuals. While effective for improving attention and executive function, these medications may also influence sleep and circadian regulation. College students are particularly vulnerable to sleep disturbances because young adulthood is characterized by a biologically delayed circadian phase that favors later sleep timing. Combined with academic and social demands and nighttime light exposure, as well as the high prevalence of delayed circadian rhythms in ADHD, these factors may increase susceptibility to circadian misalignment and sleep disruption. This mini-review provides a narrative synthesis of the current literature examining the relationship between amphetamine-type stimulant use, sleep and circadian dysregulation, and neuropsychiatric outcomes in young adults with ADHD. Understanding how stimulant pharmacology interacts with the circadian system and sleep may help optimize treatment strategies and reduce side effects in young adults with ADHD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.